Telaprevir News and Research

RSS
Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Added benefit of daclatasvir drug not proven for chronic hepatitis C infection

Added benefit of daclatasvir drug not proven for chronic hepatitis C infection

Study: Simeprevir-based therapy proves effective in treating chronic HCV infection

Study: Simeprevir-based therapy proves effective in treating chronic HCV infection

Researchers examine whether new drug offers added benefit for patients with chronic HCV

Researchers examine whether new drug offers added benefit for patients with chronic HCV

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

Biomedical scientists explore mechanisms of novel treatments for HCV

Biomedical scientists explore mechanisms of novel treatments for HCV

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Researchers identify new Chinese herbal medicine that inhibits hepatitis C virus activity

Researchers identify new Chinese herbal medicine that inhibits hepatitis C virus activity

Medivir announces phase III ATTAIN study of simeprevir inhibitor in treatment of adult patients with HCV

Medivir announces phase III ATTAIN study of simeprevir inhibitor in treatment of adult patients with HCV

Experimental drugs offer hope for people with hepatitis C

Experimental drugs offer hope for people with hepatitis C

New drug combination proves effective in treatment of hepatitis C

New drug combination proves effective in treatment of hepatitis C

LabCorp's HCV GenoSure NS3/4 test now available for Q80K polymorphism screening

LabCorp's HCV GenoSure NS3/4 test now available for Q80K polymorphism screening

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

Inovio Pharmaceuticals begins phase I clinical trial for hepatitis C vaccine

Inovio Pharmaceuticals begins phase I clinical trial for hepatitis C vaccine

FDA approves Arbor Pharmaceuticals' NDA for Nymalize oral solution

FDA approves Arbor Pharmaceuticals' NDA for Nymalize oral solution

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Baby boomers need to get tested for hepatitis C

Baby boomers need to get tested for hepatitis C

Studies demonstrate encouraging results for new direct-acting antiviral agents

Studies demonstrate encouraging results for new direct-acting antiviral agents

Vertex presents data of telaprevir Phase 3b CONCISE study in people with genotype 1 chronic HCV

Vertex presents data of telaprevir Phase 3b CONCISE study in people with genotype 1 chronic HCV